Clinical Trials
2 trialsNCT07338981 2026-01-14
The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.
British Columbia Cancer Agency
Phase 3 Not yet recruiting
NCT05485883 2022-08-08
TILUR
Tianjin Medical University Second Hospital
Phase 2 Unknown